Last reviewed · How we verify
Measles, Mumps, and Rubella Virus Vaccine Live — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Measles, Mumps, and Rubella Virus Vaccine Live (Measles, Mumps, and Rubella Virus Vaccine Live) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Measles, Mumps, and Rubella Virus Vaccine Live TARGET | Measles, Mumps, and Rubella Virus Vaccine Live | Sanofi Pasteur, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Measles, Mumps, and Rubella Virus Vaccine Live CI watch — RSS
- Measles, Mumps, and Rubella Virus Vaccine Live CI watch — Atom
- Measles, Mumps, and Rubella Virus Vaccine Live CI watch — JSON
- Measles, Mumps, and Rubella Virus Vaccine Live alone — RSS
Cite this brief
Drug Landscape (2026). Measles, Mumps, and Rubella Virus Vaccine Live — Competitive Intelligence Brief. https://druglandscape.com/ci/measles-mumps-and-rubella-virus-vaccine-live. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab